The Union Health Ministry said on Friday that five more manufactures are provided with the licence to prepare the drug Amphotericin-B. The Black fungus is treated with the help of this drug. The manufactures will start producing 1,11,000 vials of the drug per month from July.
The government is making several endeavors for the domestic availability of the drug. The Ministry said that India is importing 3,63,000 vials of Amphotericin-B drug in May, which will give a totally of 5,26,752 vials in the country. The number of vials also constitute of the domestic production. It also adds that the government will import 3,15,000 vials in June and with the domestic produce, the total tally of vials would reach to 5,70,114 in the month of June.
Various states and territories have reported a rapid increase in the cases of Black Fungus. Many states also made a request to declare it as a pandemic as it has already taken many lives. The states have also reported a shortage of the drug for treating the disease.
The Union Ministry in partnership with the Department of Pharmaceuticals and Ministry of External Affairs are making joint efforts for the domestic production of the drugs. The five manufacturers given license to produce the drug are- NATCO Pharmaceuticals, Hyderabad; Alembic Pharmaceuticals, Vadodara; Gufic Biosciences Ltd., Gujarat; Emcure Pharmaceuticals, Pune and Lyka inn Gujarat. Currently, there are only five manufacturers of the drug. These are, Bharat Serums and Vaccines Ltd., BDR Pharmaceuticals Ltd, Sun Pharma Ltd, Cipla Ltd, Life Care Innovations and Mylan Labs (importer).
Discussion about this post